The government has adopted amendments to the Ordinance on the Terms, Rules and Procedure for Regulation and Registration of the Prices of Medicinal Products.

The rule is that a medicinal product cannot be sold at medical establishments at a price higher than the value paid by public money for the relevant medicinal product formed on the basis of a reference value.

The rule applies to medical establishments under Art. 5 of the Law on the medical establishments and the medical establishments with state and / or municipal participation under art. 9 and 10 of the Medical Establishments Act.